NICE approval of adalimumab for moderate‐to‐severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
Author:
Affiliation:
1. Department of Dermatology and Academic Wound Healing Division of Infection & Immunity Cardiff University Cardiff U.K
2. HS Trust Cliffe House St Anthonys Way Rochester U.K
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.15255
Reference6 articles.
1. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
3. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
4. Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data
5. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hidradenitis suppurativa;Die Dermatologie;2024-03-21
2. Drivers of disease severity and burden of hidradenitis suppurativa: a cross‐sectional analysis on 553 German patients;International Journal of Dermatology;2023-11-02
3. Interdisziplinäres Konzept bei Akne inversa: Neue Ansätze mit Bewährtem kombinieren;Deutsches Ärzteblatt Online;2023-07-10
4. Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies;BMJ Open;2022-09
5. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study;Expert Review of Pharmacoeconomics & Outcomes Research;2021-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3